SANDOZ VIETNAM


Awards and Recognition:
 

Company details

Address

Unit 1601,
Centec Tower
72-74 Nguyen Thi Minh Khai Street,
Vo Thi Sau Ward, District 3,
Ho Chi Minh City, Vietnam

Unit 1601, Centec Tower 72-74 Nguyen Thi Minh Khai Street,
Vo Thi Sau Ward, District 3, Ho Chi Minh City, Vietnam


Industry

Pharmaceutical


Vision

Becoming the world’s leading
and most valued generics and
biosimilars company

Becoming the world’s leading and most valued generics and biosimilars company


Head Count

151


Website

www.sandoz.com


Explore opportunities with us!



www.sandoz.com/careers

www.sandoz.com/careers

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars.

At Sandoz, we discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine. The Sandoz brand is a seal of quality, and healthcare professionals around the world trust it as a symbol of high-quality, affordable medications.

At a glance, Sandoz leads the way in global off-patent medicines:


SANDOZ VIETNAM - TRUSTED HEALTHCARE PARTNER

Sandoz entered the Vietnam market in late 1990s together with Ciba-Geigy, Novartis Pharma, and other partners when Novartis set up its representative office in the country. Until May 2013, Sandoz representative offices were set up separately in Ho Chi Minh City and Hanoi to promote and support the medicine supply, and delivery of drugs to patients before joining Novartis Pharma in early 2020 to set up Novartis Vietnam Co. Ltd., the first multinational pharmaceutical company that successfully transformed into a foreign-invested enterprise and fully operationalize its import activities.

As a global leader in high-quality generics and biosimilars, our commitment in Vietnam to increase access to medicines is the basis of our day-to-day business model. Sandoz offers a broad portfolio covering major therapeutic areas such as antibiotics, oncology, cardiovascular, respiratory, osteoporosis and others, resulting in substantial savings and improved access to domestic healthcare. Over time, Sandoz Vietnam gained the trust of local healthcare professionals with their high-quality and affordable medicines and continues to support the healthcare system.

Sandoz is in the process of a proposed 100% spin-off from Novartis, planned to occur on or around October 4, 2023. Sandoz Vietnam will become a standalone company locally with a proposed timeline from Q2 2024.

SANDOZ VIETNAM – CHOICE FOR ASPIRING TALENTS

In Sandoz Vietnam, we cultivated a safe working environment aligned with our company culture by encouraging associates to do what is right and speak up to elevate their potential in achieving our purpose.

We offer competitive benefits including hybrid and flexible working, monthly Friday afternoon-off on the second week, parental leave, and activities to support associates’ wellbeing. We cultivate a culture of recognition and learning within the company to inspire and develop associates. Furthermore, we embed transparent communication with associates through regular feedback and check-in sessions to build trust with one another. Our endeavors to create a best place to work are recognized by the HR Asia Awards for two consecutive years, in 2022 and 2023.